Drug Type Gene therapy |
Synonyms DFNB 77, DFNB77 |
Target |
Action modulators |
Mechanism LOXHD1 modulators(lipoxygenase homology PLAT domains 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nonsyndromic Deafness | Preclinical | United States | 01 Jun 2025 |





